Fizazi Fizazi

Dr. Fizazi Fizazi


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2023 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
FFFizazi Fizazi
Fizazi Fizazi
ABAbdelhamid Bouramtane
Abdelhamid Bouramtane
MAMeriame Abbassi
Meriame Abbassi
YAYasser Ali El Asri
Yasser Ali El Asri
OAOmar Askander
Omar Askander
LBLaila Bouguenouch
Laila Bouguenouch

22 January 2024 in Audiology and Neurotology
Verified
Journal Article
Closed access
PDF file
FFFizazi Fizazi
Fizazi Fizazi
MAMeriame Abbassi
Meriame Abbassi
SNSamira Nmer
Samira Nmer
HLHajar Laamarti
Hajar Laamarti
MEMohamed Noureddine ElAlami
Mohamed Noureddine ElAlami
MRMohammed Ridal
Mohammed Ridal
Introduction: Despite the high genetic heterogeneity of hearing loss, mutations in the GJB2 gene are a major cause of autosomal recessive nonsyndromic hearing loss (NSHL) worldwide. However, the mutation profile of GJB2 in NSHL is under-investigated in Morocco, especially among simplex cases. This study aimed to identify the spectrum and frequency of GJB2 mutations in the Moroccan population among simplex and multiplex families with NSHL. Methods: Moroccan families with NSHL were selected according to well-defined criteria. Selected families were screened for GJB2 gene variants using direct sequencing of the entire coding region of GJB2. Results: A total of 145 affected individuals from 115 families with NSHL were included in this study (49 simplex, 66 multiplex). Mutations in the GJB2 gene were noted in 28.69% of the families (33/115), of which 75.75% were multiplex families and 24.24% were simplex. In total, seven different mutations were detected: c.35delG(p.G12fs), c.551G>A(p.R184Q), c.139G>T(p.E47X), c.109G>A(p.V37I), c.167delT(p.L56fs), c.617A>G(p.N206S), c.94C>T(p.R32C). The last three mutations have not previously been reported in Morocco. The most common GJB2 mutation was c.35delG (21.73%), followed by p.V37I (2.60%) and p.E47X (1.73%). Conclusions: Our study confirms a high prevalence of GJB2 variants in the Moroccan population, particularly the c.35delG mutation. Additionally, we have identified previously unreported or rarely reported mutations, revealing a greater diversity of GJB2 mutations. These findings emphasize the importance of comprehensive screening beyond the 35delG mutation for patients with NSHL, regardless of their family history. Integrating this approach into clinical care will enhance diagnosis and management of hearing loss in the Moroccan population.

25 May 2024 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MOMaryem Ouarhache
Maryem Ouarhache
OKOussama Kettani
Oussama Kettani
FFFizazi Fizazi
Fizazi Fizazi
LBLaila Bouguenouch
Laila Bouguenouch
KOKarim Ouldim
Karim Ouldim

22 April 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
FFFizazi Fizazi
Fizazi Fizazi
AGAmama Ghaffar
Amama Ghaffar
LBLaila Bouguenouch
Laila Bouguenouch
irum badshah saleemirum badshah saleem
irum badshah saleem
KOKarim Ouldim
Karim Ouldim
SRSaima Riazuddin
Saima Riazuddin
Hearing loss (HL) is a common sensory disorder, with syndromic forms accounting for ~30% of genetic cases. Due to phenotypic and genetic heterogeneity, accurate diagnosis remains challenging. Exome sequencing (ES) offers a powerful tool to uncover the underlying genetic causes. This study aimed to investigate the genetic basis of syndromic hearing loss (SHL) in North African Moroccan patients through ES. Seven individuals with suspected SHL were recruited from Hassan II University Hospital, Fez. After clinical and audiological assessments, ES was performed to identify causal genetic variants. Two of the participating individuals had Usher syndrome, and one each had Cornelia de Lange syndrome, Wolfram syndrome, Jervell and Lange-Nielsen syndrome, CHARGE syndrome, and Waardenburg syndrome. The causes of all these syndromes were determined, with pathogenic variants in MYO7A, USH1G, SMC1A, WFS1, KCNQ1, CHD7, and MITF. Across the combined cohort of reported Moroccan SHL cases, variants in CHD7 and MYO7A were among the most frequently observed, while USH1G and MITF variants were rare. This study enhances the understanding of SHL in North Africa, revealing a high level of locus and allelic heterogeneity. Examining disparate populations yields novel insights into the etiology of SHL, which can subsequently enhance genetic diagnosis and tailored management strategies.